(Q35543223)

English

Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).

scientific article published on 15 January 2015

Statements

Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax). (English)
J Eastham-Anderson

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit